(Q71623466)
Statements
Oral administration of IFN-alpha is superior to subcutaneous administration of IFN-alpha in the suppression of chronic relapsing experimental autoimmune encephalomyelitis (English)
Brod SA
1 February 1996
scientific article published on 01 February 1996